CLEA TECHNOLOGIES BV

Their core work

CLEA Technologies BV is a Dutch SME based in Delft specializing in enzymatic technologies for bioconversion and oxidation of biomass-derived feedstocks. Their work centers on developing and applying enzymatic processes to convert agricultural residues and underutilised seasonal biomass into bio-based products through cascading biorefinery approaches. In EU projects, they contribute specialist enzyme technology expertise — particularly enzymatic oxidation and oxyfunctionalization — to large multi-partner consortia focused on sustainable bio-based value chains. Their presence in both a BBI Joint Undertaking biorefinery project and a dedicated enzymatic oxidation RIA points to a focused niche at the intersection of industrial enzymology and the circular bioeconomy.

What they specialise in

How they've shifted over time

Both of CLEA Technologies' H2020 projects ran in the same 2016–2019 window, making it impossible to track meaningful temporal evolution from the available data. The early-period keywords describe a biorefinery-focused, feedstock-agnostic approach — cascading use, life cycle thinking, and industrial leadership — while the second project (EnzOx2) carries no keyword metadata, leaving the later direction underspecified. Based on project titles alone there is a possible shift from broad biorefinery systems integration (BIOrescue) toward more targeted enzymatic chemistry (EnzOx2), but this remains speculative given the data limitations.

With only two concurrent projects and no recorded H2020 activity beyond 2019, CLEA Technologies appears to occupy a stable specialist niche in enzyme-based bioconversion, but it is unclear whether they continued or expanded this trajectory in subsequent funding periods.

How they like to work

CLEA Technologies has participated exclusively as a non-coordinating partner across both projects, indicating they operate as a specialist technology contributor rather than a project driver. Despite only two projects, they engaged with 22 unique partners across 10 countries, reflecting participation in the large multi-partner consortia typical of BBI Joint Undertaking and broad RIA calls. This profile suits an organisation that brings a well-defined technical capability to wider value chain consortia rather than building and managing research networks themselves.

CLEA Technologies connected with 22 unique partners across 10 countries through just two projects, reflecting the large consortium structures common in BBI-JU bioeconomy calls. No dominant geographic clustering is apparent from the available data beyond their Dutch base.

What sets them apart

CLEA Technologies offers a focused and rare capability — enzymatic process technology for biomass valorisation — from within the Delft science and technology ecosystem, which hosts world-class expertise in industrial microbiology and bioprocess engineering. As an SME, they bring applied, commercially-oriented enzyme know-how to consortia that typically skew toward academic partners, making them a practical bridge between laboratory research and industrial implementation. Their combination of biorefinery systems thinking (BIOrescue) and precision enzymatic chemistry (EnzOx2) positions them as a connector between feedstock-level bioeconomy projects and molecular-scale biotechnology.

Highlights from their portfolio

• EnzOx2
  Directly reflects CLEA's core technical identity — enzymatic oxidation and oxyfunctionalization — making it the clearest evidence of their specialist capability in the H2020 portfolio.
• BIOrescue
  The only project with recorded EC funding and the richest keyword metadata; BBI Joint Undertaking funding signals the industrial relevance and commercial applicability of the biorefinery work.